Clinical Indication

Treatment of seizures associated with Dravet syndrome as an add-on therapy to other anti-epileptic medicines.

Date of classification

March 2022


Not yet reviewed drugs with no traffic light recommendation so not yet approved for use in LLR.

  • New medicines, devices, appliances.
  • New indication of existing medicine.
  • New NICE TA which has not been reviewed.
  • Not been requested for review by either TAS/LPT MMC.